glp 1 and vyvanse tirzepatide Torzepatide and Adhd GLP-1 Therapy Weight Loss Medication
Description
Its likely due to changes in digestion, gut motility, and diet
These advancements have the potential to significantly change how we treat metabolic diseases in the future
5 Cawley J, Meyerhoefer C
French recommends focusing on intensity rather than volume when energy intake is lower and scaling sessions based on recovery
For someone losing 1520% of their body weight, this can mean significant muscle loss, with real consequences for metabolic health, mobility, and long-term outcomes
